![Judy Chou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Judy Chou
Chief Executive Officer at
Altrubio, Inc.
Profile
Judy Chou is currently President, Chief Executive Officer & Director at AltruBio, Inc. since 2020.
Former positions include Independent Director at Akero Therapeutics, Inc. from 2021 to 2025, Director & Member-Governors Board at Biocom, Inc. from 2019 to 2020, and Senior Vice President & Global Head-Biotech at Bayer Pharmaceuticals.
Education includes a doctorate from Yale University.
Judy Chou active positions
| Companies | Position | Start |
|---|---|---|
Altrubio, Inc.
 Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Chief Executive Officer | 31/12/2019 |
Former positions of Judy Chou
| Companies | Position | End |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Board Member | 08/12/2025 |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Director/Board Member | 18/11/2020 |
Bayer Pharmaceuticals
 Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Corporate Officer/Principal | - |
Training of Judy Chou
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Health Technology |
- Stock Market
- Insiders
- Judy Chou
